The European Investment Bank (EIB) has extended a €37.5 Million loan facility agreement to Nyxoah, a medical technology company specializing in innovative solutions for obstructive sleep apnea. This significant financial boost will support Nyxoah's R&D activities, scale-up manufacturing and finalize regulatory process to expand market reach. CFO Loïc Moreau highlights the strategic importance of this funding, emphasizing its role in advancing Nyxoah's technological developments and improving patient outcomes. Moreau also underscores the EIB's confidence in Nyxoah's vision and potential, marking a pivotal step towards enhancing sleep health worldwide. #Nyxoah #Genio #OSA #innovation #sleepapneatreatment #medtech #makesleepsimpleagain #restfulnights